7780 Daiken Biomedical*

Disclosure Date: 1150715 Statement Date: 1150714 Statement Time: 151620 Company Code: 7780 Company Name: Daiken Biomedical* Subject: Announcement on behalf of Australian subsidiary Daiken Investment One Australia Pty Ltd regarding proposed acquisition of Australian real estate Applicable Clause: Clause 20 Factual Date: 1150714 Details: 1. Name and nature of the subject property (e.g., land located in Section XX, Subsection XX, North District, Taichung City): Property Name: 10 Browning Street Property Address: 10 Browning Street, South Brisbane, 4101, QLD, AU

2. Factual Date: 115/7/14 ~ 115/7/14

3. Board Approval Date: July 14, 115 (Minguo Calendar)

4. Other Approval Dates: Not applicable

5. Quantity of units (e.g., XX square meters, converted to XX ping), unit price, and total transaction amount: Land Area: 4,564 square meters Building Area: 13,417 square meters Total Transaction Amount: AUD 81,139,000

6. Counterparty and its relationship with the company (if the counterparty is an individual and not a related party of the company, name disclosure may be omitted): Counterparty: C/- Forza Capital Pty Ltd Relationship with the company: None

7. If the counterparty is a related party, state the reason for selecting the related party as the transaction party, the previous transferor, the relationship between the previous transferor and the company and the counterparty, the previous transfer date, and the transfer amount: Not applicable

8. If the property’s owner within the past five years was a related party of the company, disclose the related party’s acquisition and disposal date, price, and relationship with the company at the time of transaction: Not applicable

9. Estimated gain (or loss) from disposal (not applicable for asset acquisition) (deferred gains/losses should be listed with recognition details): Not applicable

10. Delivery or payment terms (including payment periods and amounts), contractual restrictions, and other important agreements: As stipulated in the contract

11. Decision method for this transaction (e.g., bidding, comparison, or negotiation), reference basis for price determination, and decision-making unit: Price Determination: Based on market conditions and valuation reports Decision-Making Unit: Board of Directors

12. Name of professional valuation firm or company and its valuation amount: CBRE Valuations Pty Ltd: AUD 81,000,000 Cushman & Wakefield (Valuations) Pty Ltd: AUD 80,000,000

13. Name of professional valuer: CBRE Valuations Pty Ltd: Edward Hale Cushman & Wakefield (Valuations) Pty Ltd: Hugo Yang

14. Professional Valuer’s License Number: CBRE: Edward Hale Registration No: 4072 Cushman & Wakefield: Hugo Yang Registration No: 3355

15. Whether the valuation report is for a limited price, specific price, or special price: No or not applicable

16. Whether the valuation report has not yet been obtained: No or not applicable

17. Reason for not obtaining the valuation report: Not applicable

18. Reasons for significant differences in valuation results and auditor’s opinion: No significant differences

19. Name of auditing firm: Not applicable

20. Auditor’s name: Not applicable

21. Auditor’s license number: Not applicable

22. Broker and brokerage fees: Not applicable

23. Specific purpose or use of the acquisition or disposal: Investment needs

24. Opinions of directors who objected to this transaction: None

25. Whether this transaction is a related-party transaction: No

26. Date of supervisor’s approval or audit committee’s consent: Not applicable

27. Whether this transaction involves acquiring real estate or its right-of-use assets from a related party: No

28. Valuation amount assessed under Article 16 of the 'Asset Acquisition and Disposal Rules for Publicly Issued Companies': Not applicable

29. Valuation amount assessed under Article 17 of the same rules if the valuation under the previous item is lower than the transaction price: Not applicable

30. Previous date of material information disclosure regarding the same event: Not applicable

31. Other explanatory matters: None